16624411000001100: Terbinafine 250mg tablets (Viatris UK Healthcare Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\UK product\Virtual medicinal product\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing terbinafine\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing terbinafine\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing terbinafine\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing terbinafine\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing terbinafine\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing terbinafine\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antifungal agent (product)\Product containing terbinafine\Terbinafine\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antifungal agent (product)\Product containing terbinafine\Terbinafine\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antifungal agent (product)\Product containing terbinafine\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing terbinafine in oral dose form (medicinal product form)\Product containing only terbinafine in oral dose form (medicinal product form)\Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet\Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Mar 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2121981000001117 Terbinafine 250mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2121991000001115 Terbinafine 250mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58098201000001110 Terbinafine 250mg tablets (Generics (UK) Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
58098301000001118 Terbinafine 250mg tablets (Generics (UK) Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
92789501000001111 Terbinafine 250mg tablets (Mylan Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
105644601000001114 Terbinafine 250mg tablets (Mylan) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Is a	Product containing precisely terbinafine (as terbinafine hydrochloride) 250 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has active ingredient	Terbinafine hydrochloride	false	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has specific active ingredient	Terbinafine hydrochloride	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Terbinafine	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Has basis of strength substance	Terbinafine	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Terbinafine 250mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets	Has AMP	True	Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2121981000001117	Terbinafine 250mg tablets (Viatris UK Healthcare Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2121991000001115	Terbinafine 250mg tablets (Viatris UK Healthcare Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
58098201000001110	Terbinafine 250mg tablets (Generics (UK) Ltd) (product)	en	Fully specified name	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
58098301000001118	Terbinafine 250mg tablets (Generics (UK) Ltd)	en	Synonym	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
92789501000001111	Terbinafine 250mg tablets (Mylan Ltd)	en	Synonym	Inactive	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
105644601000001114	Terbinafine 250mg tablets (Mylan)	en	Synonym	Inactive	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module